GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Benchmark Holdings PLC (LSE:BMK) » Definitions » EV-to-EBIT

Benchmark Holdings (LSE:BMK) EV-to-EBIT : -50.50 (As of May. 02, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Benchmark Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Benchmark Holdings's Enterprise Value is £401.1 Mil. Benchmark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.9 Mil. Therefore, Benchmark Holdings's EV-to-EBIT for today is -50.50.

The historical rank and industry rank for Benchmark Holdings's EV-to-EBIT or its related term are showing as below:

LSE:BMK' s EV-to-EBIT Range Over the Past 10 Years
Min: -2771.94   Med: -52.6   Max: 390.55
Current: -50.5

During the past 12 years, the highest EV-to-EBIT of Benchmark Holdings was 390.55. The lowest was -2771.94. And the median was -52.60.

LSE:BMK's EV-to-EBIT is ranked worse than
100% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.56 vs LSE:BMK: -50.50

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Benchmark Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was £332.4 Mil. Benchmark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was £-7.9 Mil. Benchmark Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -2.39%.


Benchmark Holdings EV-to-EBIT Historical Data

The historical data trend for Benchmark Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benchmark Holdings EV-to-EBIT Chart

Benchmark Holdings Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.85 -23.31 -417.57 -35.49 -158.11

Benchmark Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -736.02 -682.82 52.74 -158.11 -41.85

Competitive Comparison of Benchmark Holdings's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Benchmark Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benchmark Holdings's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Benchmark Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Benchmark Holdings's EV-to-EBIT falls into.



Benchmark Holdings EV-to-EBIT Calculation

Benchmark Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=401.116/-7.943
=-50.50

Benchmark Holdings's current Enterprise Value is £401.1 Mil.
Benchmark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was £-7.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings  (LSE:BMK) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Benchmark Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-7.943/332.445356
=-2.39 %

Benchmark Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was £332.4 Mil.
Benchmark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was £-7.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benchmark Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Benchmark Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Benchmark Holdings (LSE:BMK) Business Description

Traded in Other Exchanges
Address
Yeoman Way, Highdown House, Worthing, West Sussex, GBR, BN99 3HH
Benchmark Holdings PLC is engaged in the healthcare sector. Its operating segment includes Genetics; Advanced Nutrition; Health; and Corporate. The company generates maximum revenue from the Advanced Nutrition segment. The Advanced Nutrition segment manufactures and provides technically advanced nutrition and health products to the aquaculture industry. Geographically, it derives a majority of its revenue from Norway and also has a presence in Vietnam; the Faroe Islands; Ecuador; India; Greece; Canada; Chile, and the Rest of World.

Benchmark Holdings (LSE:BMK) Headlines

No Headlines